Larimar Therapeutics (LRMR) Change in Account Payables (2016 - 2020)
Historic Change in Account Payables for Larimar Therapeutics (LRMR) over the last 8 years, with Q4 2020 value amounting to $905000.0.
- Larimar Therapeutics' Change in Account Payables rose 11244.13% to $905000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was -$3.3 million, marking a year-over-year decrease of 22501.9%. This contributed to the annual value of $1.1 million for FY2024, which is 38312.66% up from last year.
- As of Q4 2020, Larimar Therapeutics' Change in Account Payables stood at $905000.0, which was up 11244.13% from -$909000.0 recorded in Q3 2020.
- In the past 5 years, Larimar Therapeutics' Change in Account Payables ranged from a high of $2.5 million in Q2 2017 and a low of -$4.1 million during Q1 2016
- Over the past 5 years, Larimar Therapeutics' median Change in Account Payables value was -$346000.0 (recorded in 2018), while the average stood at -$220150.0.
- As far as peak fluctuations go, Larimar Therapeutics' Change in Account Payables surged by 76647.4% in 2016, and later crashed by 46719.1% in 2020.
- Quarter analysis of 5 years shows Larimar Therapeutics' Change in Account Payables stood at -$1.1 million in 2016, then soared by 132.21% to $344000.0 in 2017, then skyrocketed by 140.99% to $829000.0 in 2018, then crashed by 48.61% to $426000.0 in 2019, then soared by 112.44% to $905000.0 in 2020.
- Its Change in Account Payables stands at $905000.0 for Q4 2020, versus -$909000.0 for Q3 2020 and -$760000.0 for Q2 2020.